Clinical Trial Update: A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia [NA]

View source ↗

Summary

A double-blind, randomized trial studied adding celecoxib to risperidone in treatment-naive first-episode schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Celecoxib (Celecoxib)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Beijing HuiLongGuan Hospital | Conditions: Schizophrenia | NA | Status: COMPLETED